At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Percutaneous coronary intervention (NG PROMUS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everolimus-Eluting Platinum Chromium Coronary Stent System (NG PROMUS Stent System) for the Treatment of Atherosclerotic Lesion(s)
In Brief
A clinical study evaluating Percutaneous coronary intervention (NG PROMUS) for Atherosclerosis and Coronary Artery Disease. Completed, enrolled 100 participants across 9 sites in 3 countries.
Detailed Summary
NG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everolimus-Eluting Platinum Chromium Coronary Stent System (NG PROMUS Stent System) for the Treatment of Atherosclerotic Lesion(s)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis, Coronary Artery Disease
CountriesAustralia, New Zealand, Singapore
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 2012
Enrollment StartNov 2012
Primary CompletionMar 2013
TodayJul 2026
First PostedOct 10, 2012
Enrollment StartNov 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.7 years ago
Interventions
Percutaneous coronary intervention (NG PROMUS)device
Interventional coronary artery stenting with NG PROMUS study stent.